Ultimovacs
2011
FOUNDED
PUBLIC
STATUS
21-30
EMPLOYEES
ULTIMO
STOCK SYMBOL
1
INVESTMENTS
$3.32
SHARE PRICE
(As of Friday Closing)
Description
Ultimovacs ASA is a Norway based pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
OSL
Primary Office
- Ullernchausséen 64
- 0379 Oslo
- Norway
+47 413 00 000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ultimovacs’s full profile, request a free trial.
Ultimovacs Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $3.21 - $4.00 | $92.4M | $3.32 | -$0.24 | 6.43K | 27.9M |
Ultimovacs Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 90,753 | |||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (5,732) | (6,869) | (3,974) | (3,414) |
| Net Income | (5,678) | (6,788) | (3,970) | (3,448) |
| Total Assets | 61,093 | 21,792 | 21,777 | 9,558 |
| Total Debt | 430 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Ultimovacs Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Ultimovacs‘s full profile, request access.
Request full access to PitchBookUltimovacs Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 03-Sep-2018 | 0000000000 | 00.000 | Drug Discovery | 0000 0000000 00.0 |
Ultimovacs Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Drug Discovery | Uppsala, Sweden | 0000 |
Ultimovacs Executive Team (7)
1 Former Executive
You’re viewing 5 of 7 executives. Get the full list »Ultimovacs Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 00000000 000000 | Self | Board Member | 000 0000 | |
| 00ø00 00000000 | Gjelsten Holding | Board Member | 000 0000 | |
| 000000 000ü00000 | Gjelsten Holding | Board Member | 000 0000 | |
| 00000 000000000 00 | Self | Board Member | 000 0000 | |
| 00000 000000000 | Ultimovacs | Chairman | 000 0000 |